Synapse - Craig Moskowitz

Search Within

Craig Moskowitz

Results (407)

Case-based learning in continuing education: Improving hematologist/oncologist evidence-based decisions for preventing Hogdkin lymphoma post-transplant relapse

Meeting Abstract

Repetto, P.; Moskowitz, C.
Haematologica (2017)

Fulltext@MSK | Save

Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma

Journal Article

Chen, R.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N. A.; Brice, P.; Radford, J.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma

Journal Article

Bröckelmann, P. J.; Müller, H.; Casasnovas, O.; Hutchings, M.; von Tresckow, B.; Jürgens, M.; McCall, S. J.; Morschhauser, F.; Fuchs, M.; Borchmann, P.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era

Meeting Abstract

Batlevi, C.; Alperovich, A.; Ni, A.; Soumerai, J.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma

Meeting Abstract

Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma

Meeting Abstract

Sauter, C. S.; Matasar, M. J.; Schoder, H.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)

Meeting Abstract

Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Dose and/or volume reduction using consolidation volume radiation therapy (CVRT) lowers dose to heart and lungs in early-stage Hodgkin lymphoma patients with bulky disease

Meeting Abstract

Yang, J. C.; Kumar, A.; Chapman, K. L.; Burleson, S.; Huang, C.; Constine, L. S.; Hoppe, R. T.; Dandapani, S.; Straus, D. J.; Moskowitz, C. H.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save

Phase 1B study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): Updated results from the KEYNOTE-013 trial

Meeting Abstract

Zinzani, P.; Ribrag, V.; Moskowitz, C. H.; Michot, J.; Kuruvilla, J.; Bartlett, N.; Balakumaran, A.; Chatterjee, A.; Chlosta, S.; Shipp, M. A.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save